» Sur le Web » Clinical Trials News From Medical News Today
 
lundi 18 février 2019

 
 

Clinical Trials News From Medical News Today
 

Latest Clinical Trials News From Medical News Today.

Les derniers articles du site :
 
Advocacy Groups Charge Schering-Plough With Racial Discrimination For Excluding Blacks From Hepatitis C Trial
Two advocacy groups last week said Schering-Plough is discriminating against black people by excluding them from the Phase II clinical trial of its new hepatitis C therapy, the ... click link for more info.
mercredi 5 avril 2006
 
New Reversible Male Contraceptive That Provides 10 Or More Years Of Protection After A 10-15 Minute Procedure
Tyler Dunlap, a 27-year-old newlywed in San Francisco, is just one of the many American men eagerly awaiting the results of a large clinical trial in India.The trial is studying a new male contraceptive, RISUG (Reversible Inhibition of Sperm Under Guidance): a reversible, nonhormonal (...)
mardi 4 avril 2006
 
New Reversible Male Contraceptive That Provides 10 Or More Years Of Protection After A 10-15 Minute Procedure
Tyler Dunlap, a 27-year-old newlywed in San Francisco, is just one of the many American men eagerly awaiting the results of a large clinical trial in India.The trial is studying a new male contraceptive, RISUG (Reversible Inhibition of Sperm Under Guidance): a reversible, nonhormonal contraceptive that provides 10 or more years of protection after a 10-15 minute procedure... click link for more info.
mardi 4 avril 2006
 
Bird Flu Vaccine Dosing To Be Tested In Clinical Trial By Duke University Medical Center
A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center.The Duke study is part of a multicenter trial that will test a modified form of an investigational bird flu vaccine to determine whether the (...)
lundi 3 avril 2006
 
Bird Flu Vaccine Dosing To Be Tested In Clinical Trial By Duke University Medical Center
A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center.The Duke study is part of a multicenter trial that will test a modified form of an investigational bird flu vaccine to determine whether the vaccine still triggers a strong immune response at lower doses... click link for more info.
lundi 3 avril 2006
 
UK Premature Baby Ventilation Trial Cleared Of Causing Long-term Harm To Participants
Premature babies with breathing problems who were given continuous negative-extrathoracic-pressure (CNEP) ventilation in a UK trial do not have poorer long-term outcomes when compared with those who received standard treatment, concludes a study in this week's issue of The Lancet.CNEP is a (...)
lundi 3 avril 2006
 
UK Premature Baby Ventilation Trial Cleared Of Causing Long-term Harm To Participants
Premature babies with breathing problems who were given continuous negative-extrathoracic-pressure (CNEP) ventilation in a UK trial do not have poorer long-term outcomes when compared with those who received standard treatment, concludes a study in this week's issue of The Lancet.CNEP is a treatment where pressure is applied to a child's chest to assist breathing... click link for more info.
lundi 3 avril 2006
 
First Clinical Trial Of Gene Therapy For Muscular Dystrophy Now Under Way
The first gene therapy human trial in the United States for a form of muscular dystrophy is under way.The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina at (...)
samedi 1er avril 2006
 
First Clinical Trial Of Gene Therapy For Muscular Dystrophy Now Under Way
The first gene therapy human trial in the United States for a form of muscular dystrophy is under way.The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina at Chapel Hill's School of Medicine and the University of Pittsburgh... click link for more info.
samedi 1er avril 2006
 
COPD - AstraZeneca Welcomes Preliminary Results From TORCH
AstraZeneca (LSE: AZN , NYSE: AZN) has welcomed preliminary results from the TORCH (TOwards a Revolution in COPD Health) study1, suggesting combination therapies containing an inhaled corticosteroid (ICS) and long-acting beta 2 agonist (LABA) have the potential to show mortality benefits for (...)
samedi 1er avril 2006
 
Accueil     |    Plan du site     |    Espace rédacteurs     |    Se connecter
  Mis à jour le vendredi 8 février 2019